The Gabelli Healthcare & Wellness Trust (GRX): fair value, margin of safety and Wheel Score

Is GRX undervalued?

GRX closed at 10.41 on 5 Nov 2026 against a GLS average fair value of 10.79 - 3.5% below fair value, which our scans read as "fairly priced". 3 of 8 models are above the current price. There is no discount to lean on here, so the margin of safety is not the reason to look at the stock.

There is a wide gap between GLS Growth (1.65) and Graham Growth (32.23). When the models are this far apart the "fair value" is really a range, and the margin of safety above should be read with that range in mind.

Ranked against every other company we cover, neither cheapness nor growth clearly wins for GRX, so the nightly engine files it under Blend (value score 53, growth score 59, out of 100). It also carries the Income tag (Income = a dividend yield of 4% or more).

Nine valuation models for GRX

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

Quality and financial health

The Gabelli Healthcare & Wellness Trust scores only 4 of 9 on the Piotroski F-score, which fails the "Piotroski 6 or more" Wheel Trade Filter. A reading this low means several of the basic tests - positive earnings, positive operating cash flow, falling debt, no new share issuance - are not met. A GLS Moat score of 3.8/10 is a weak reading: the accounts do not show returns and margins that competitors have been unable to wear down, so the Moat part of the Wheel Score contributes little.

Returns on capital are thin or negative - ROIC 1.0%, ROE 1.4%, ROA 0.9% - with debt at 0.45 times equity and a free-cash-flow yield of 2.6%.

The dividend yield is high at 6.53% (payout ratio 124%) - a payout above 100% of earnings, which is not covered by profits. A yield this size is often the market's way of pricing a risk to the payout, so the health score and cash flow matter more than usual.

Institutional ownership scores 5/10, insider activity 10/10 and Congressional trading 5/10 on the GLS smart-money scales; the last recorded insider buy was on 2 Nov 2026.

Wheel Score 17: No options

No options are listed on The Gabelli Healthcare & Wellness Trust in our nightly snapshot, so it fails the first Wheel Trade Filter (options that actually trade) (it reads 17, under 70) and is left out of every options scan; the fair value and health figures above are still useful for a plain stock position.

Volume runs at 68k shares a day on a market cap of $151M, with a beta of 0.82; the Stability part of the Wheel Score rates that fair.

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls: a stock must pass all 9 Wheel Trade Filters to score 70, and the score then ranks the ones that pass; the Sunday Scan is the top 10. It is updated nightly and is not a recommendation. How the Wheel Score works · the walkthrough lesson shows how it fits into a trade, start to finish.

Upcoming events

No upcoming earnings date is recorded for GRX in the nightly calendar.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Asset Management

The 12 companies below are the closest to The Gabelli Healthcare & Wellness Trust by market cap within the Asset Management industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

⚖ Compare GRX with 7 of them   All Financial Services stocks →